Induslaw Deal Report - Citigroup Global Markets India Private Limited

I
IndusLaw

Contributor

INDUSLAW is a multi-speciality Indian law firm, advising a wide range of international and domestic clients from Fortune 500 companies to start-ups, and government and regulatory bodies.
We advised Citigroup Global Markets India Private Limited in relation to the sale of equity shares of Concord Biotech Limited held by 1575773 Ontario Inc for INR 519 crores, through block trade.
India Corporate/Commercial Law
To print this article, all you need is to be registered or login on Mondaq.com.

We advised Citigroup Global Markets India Private Limited in relation to the sale of equity shares of Concord Biotech Limited held by 1575773 Ontario Inc for INR 519 crores, through block trade.

Deal amount: INR 519 crores/ USD 62 million

INDUSLAW team: Vishal Yaduvanshi (Partner), Priyadarshini Rao (Partner) and Abishek Sankar (Associate)

Other law firms involved:

  • Sidley Austin LLP

* Concord Biotech block deal: 3.4% equity changes hands as Ontario Inc pares stake (moneycontrol.com)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More